Meanwhile, dose intensity, history of cholelithiasis, ALT, AST and Hb were related risk factors of HFS: reductions of dose intensity and WBC was a related risk factor of OM, and reductions of dose intensity, history of cholelithiasis and WBC was a related risk factor of simultaneous incidence of HFS and OM. Here, GSTM1 is linked to cholelithiasis.